Press release
Acute-on-Chronic Liver Failure Market to Witness Growth by 2032, Estimates DelveInsight | Grifols Therapeutics, Versantis AG, HepaStem
The Acute-on-Chronic Liver Failure market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acute-on-Chronic Liver Failure pipeline products will significantly revolutionize the Acute-on-Chronic Liver Failure market dynamics.DelveInsight's "Acute-on-Chronic Liver Failure Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Acute-on-Chronic Liver Failure, historical and forecasted epidemiology as well as the Acute-on-Chronic Liver Failure market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Acute-on-Chronic Liver Failure market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Acute-on-Chronic Liver Failure market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acute-on-Chronic Liver Failure Market Insights [https://www.delveinsight.com/sample-request/acute-on-chronic-liver-failure-aclf-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Acute-on-Chronic Liver Failure Market Report:
* The Acute-on-Chronic Liver Failure market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
* According to CANONIC study the prevalence of Acute-on-Chronic Liver Failure grade 1, 2, and 3 was 49%, 35%, and 16%, respectively
* The most frequent precipitating disorders for acutely decompensated cirrhosis, with or without Acute-on-Chronic Liver Failure, were both hepatic (alcohol-induced liver injury) and extrahepatic (bacterial infections or gastrointestinal haemorrhage)
* Ruben Hernez found that the global prevalence of Acute-on-Chronic Liver Failure among patients admitted for decompensated cirrhosis was 35% (95% CI, 33%-38%). The region with the highest prevalence was South Asia at 65%, followed by
* Europe at 39%
* Key Acute-on-Chronic Liver Failure Companies: Grifols Therapeutics, Versantis AG, HepaStem, and others
* Key Acute-on-Chronic Liver Failure Therapies: PE-A (Albutein-5%), VS-01, and others
* The Acute-on-Chronic Liver Failure epidemiology based on gender analyzed that grade 1 cases accounted for maximum number of Acute-on-Chronic Liver Failure cases
Acute-on-Chronic Liver Failure Overview
The term 'acute-on-chronic liver failure' (ACLF) defines an abrupt and life-threatening worsening of clinical conditions in patients with cirrhosis or chronic liver disease. ACLF is a serious condition with very high morbidity and mortality. According to European Association for the Study of the Liver - Chronic Liver Failure (EASL-CLIF) Consortium the definition of ACLF is based on the existence of the failure of 1 of the 6 major organ systems. The failure of each organ system is assessed using the CLIF-C Organ Failure scale.
Get a Free sample for the Acute-on-Chronic Liver Failure Market Report:
https://www.delveinsight.com/report-store/acute-on-chronic-liver-failure-aclf-market [https://www.delveinsight.com/report-store/acute-on-chronic-liver-failure-aclf-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Acute-on-Chronic Liver Failure Market
The dynamics of the Acute-on-Chronic Liver Failure market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
Acute-on-Chronic Liver Failure Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Acute-on-Chronic Liver Failure Epidemiology Segmentation:
The Acute-on-Chronic Liver Failure market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
* Total Prevalence of Acute-on-Chronic Liver Failure
* Prevalent Cases of Acute-on-Chronic Liver Failure by severity
* Gender-specific Prevalence of Acute-on-Chronic Liver Failure
* Diagnosed Cases of Episodic and Chronic Acute-on-Chronic Liver Failure
Download the report to understand which factors are driving Acute-on-Chronic Liver Failure epidemiology trends @ Acute-on-Chronic Liver Failure Epidemiological Insights [https://www.delveinsight.com/sample-request/acute-on-chronic-liver-failure-aclf-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Acute-on-Chronic Liver Failure Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Acute-on-Chronic Liver Failure market or expected to get launched during the study period. The analysis covers Acute-on-Chronic Liver Failure market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Acute-on-Chronic Liver Failure Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
To know more about Acute-on-Chronic Liver Failure treatment, visit @ Acute-on-Chronic Liver Failure Medications [https://www.delveinsight.com/sample-request/acute-on-chronic-liver-failure-aclf-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Acute-on-Chronic Liver Failure Therapies and Key Companies
* PE-A (Albutein-5%): Grifols Therapeutics
* VS-01 : Versantis AG
* Promethera Biosciences: HepaStem
Scope of the Acute-on-Chronic Liver Failure Market Report
* Study Period: 2019-2032
* Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
* Key Acute-on-Chronic Liver Failure Companies: Grifols Therapeutics, Versantis AG, HepaStem, and others
* Key Acute-on-Chronic Liver Failure Therapies: PE-A (Albutein-5%), VS-01, and others
* Acute-on-Chronic Liver Failure Therapeutic Assessment: Acute-on-Chronic Liver Failure current marketed and Acute-on-Chronic Liver Failure emerging therapies
* Acute-on-Chronic Liver Failure Market Dynamics: Acute-on-Chronic Liver Failure market drivers and Acute-on-Chronic Liver Failure market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Acute-on-Chronic Liver Failure Unmet Needs, KOL's views, Analyst's views, Acute-on-Chronic Liver Failure Market Access and Reimbursement
Discover more about therapies set to grab major Acute-on-Chronic Liver Failure market share @ Acute-on-Chronic Liver Failure market forecast [https://www.delveinsight.com/sample-request/acute-on-chronic-liver-failure-aclf-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Acute-on-Chronic Liver Failure Market Report Introduction
2. Executive Summary for Acute-on-Chronic Liver Failure
3. SWOT analysis of Acute-on-Chronic Liver Failure
4. Acute-on-Chronic Liver Failure Patient Share (%) Overview at a Glance
5. Acute-on-Chronic Liver Failure Market Overview at a Glance
6. Acute-on-Chronic Liver Failure Disease Background and Overview
7. Acute-on-Chronic Liver Failure Epidemiology and Patient Population
8. Country-Specific Patient Population of Acute-on-Chronic Liver Failure
9. Acute-on-Chronic Liver Failure Current Treatment and Medical Practices
10. Acute-on-Chronic Liver Failure Unmet Needs
11. Acute-on-Chronic Liver Failure Emerging Therapies
12. Acute-on-Chronic Liver Failure Market Outlook
13. Country-Wise Acute-on-Chronic Liver Failure Market Analysis (2019-2032)
14. Acute-on-Chronic Liver Failure Market Access and Reimbursement of Therapies
15. Acute-on-Chronic Liver Failure Market Drivers
16. Acute-on-Chronic Liver Failure Market Barriers
17. Acute-on-Chronic Liver Failure Appendix
18. Acute-on-Chronic Liver Failure Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=acuteonchronic-liver-failure-market-to-witness-growth-by-2032-estimates-delveinsight-grifols-therapeutics-versantis-ag-hepastem]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute-on-Chronic Liver Failure Market to Witness Growth by 2032, Estimates DelveInsight | Grifols Therapeutics, Versantis AG, HepaStem here
News-ID: 3445677 • Views: …
More Releases from ABNewswire

Bedrock Restoration - Water Fire Mold Damage Service, Expands Water Damage Repai …
Water Fire Mold Damage Service, a trusted provider of property restoration, has announced expanded service offerings to meet the growing demand for professional water damage solutions in the region. Known for their reliable, customer-focused approach, the company continues to support both homeowners and businesses in recovering from unexpected property damage caused by water, fire, or mold.
Responding to a Growing Need for Water Damage Restoration
Property owners across Minnesota are increasingly seeking…

Winkler Kurtz LLP Expands Resources to Handle Increased Demand for Personal Inju …
For individuals searching for personal injury attorneys, the expansion of Winkler Kurtz LLP's team means greater accessibility and reduced wait times for consultations. The firm's deep roots in the Port Jefferson Station community allow them to understand local nuances, such as common accident hotspots and specific regional legal precedents.
Port Jefferson Station has seen a notable rise in personal injury cases, driven by factors such as increased traffic congestion, construction activity,…

Protecting Property Value: Hose Bros Inc Highlights How Professional Power Washi …
For residents searching for power washing near me, Hose Bros Inc offers accessible and reliable services tailored to the Millsboro community. Their local expertise ensures an understanding of regional challenges, such as the impact of salt air on coastal properties or the tendency for humidity to promote mold growth in shaded areas. This knowledge allows them to customize their approach, selecting appropriate pressure levels and cleaning agents for different surfaces.
In…
![Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Prices](https://cdn.open-pr.com/9/1/914818326_g.jpg)
Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Price …
A 2025 cost guide to kitchen, bathroom, and full home remodeling in Tampa Bay, featuring expert insights from Craftline Remodeling on pricing, budgeting, and contractor selection.
Market Overview: Understanding Tampa Bay Remodeling Investment Trends
Tampa Bay's home remodeling market has experienced significant cost evolution in 2025, with project expenses varying dramatically across South Tampa, Carrollwood, Seminole Heights, Clearwater, St. Petersburg, and Wesley Chapel based on material choices, project scope, and contractor expertise.…
More Releases for Liver
Rising Liver Disease Cases Drive Growth In Liver Metastases Treatment Market Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Liver Metastases Treatment Market Size By 2025?
The market for treating liver metastases has seen significant growth in the past few years. It is projected to increase from $1.57 billion in 2024 to $1.71 billion in 2025, with a compound annual growth rate (CAGR) of…
LivCare Liver Support
The liver plays a crucial role in maintaining overall well-being, performing essential functions like detoxification, digestion, and metabolism. However, many people overlook the importance of liver health until problems arise. LivCare Liver Support is a premium supplement designed to keep your liver in peak condition. By incorporating this supplement into your daily routine, you can help ensure your liver functions optimally, leading to better overall health.
● Product Name - LivCare…
Liver Cancer Therapeutics Market - Empowering Recovery, Restoring Health: Innova …
Newark, New Castle, USA - new report, titled Liver Cancer Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liver Cancer Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liver Cancer Therapeutics market. The report offers an overview of…
Liver Health Supplements Market Grows Strong as Consumers Adopt Proactive Measur …
Global liver health supplements market was valued at US$ 8.7 Bn in 2021, is growing at an estimated CAGR of 5.8% over the forecast period (2022 - 2030). The liver health supplements market is growing due to the increasing awareness of the importance of liver health and the rise of lifestyle-related liver diseases. The market offers a wide range of supplements that help in improving liver function, supporting liver detoxification,…
Urgent Liver 911 Reviews 2021: Is Urgent Liver 911 Legit?
Urgent Liver 911 by PhytAge Laboratories is a powerful diet that promotes liver function by combining natural minerals and nutrients. The diet is made up of plant and herbal extracts that collectively aid in liver cell protection. While the liver is an important human organ that promotes general health and vitality, most people are unaware that even those who appear to be in good health can be affected by liver…
Liver Extract Power Exporter, Liver Extract Product, Liver Extract Crude, Liver …
Titan Biotech is an ISO 9001:2000 Certified Company, established with an objective of serving Scientific Community and providing good quality of Biological Products, Biotechnology Products, Biological Extracts and their derivatives. Liver Extract Power Exporter is produced from specific fraction of beef liver. Liver Extract is rich in vital nutrients including energy producing B Vitamins and serve as an excellent source of proteins. Liver Extract is capable of stimulating the production…